10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,821,907 | -45.0% | 189,622 | -25.5% | 0.00% | -40.0% |
| Q2 2023 | $14,218,986 | +99208.5% | 254,638 | -0.8% | 0.01% | 0.0% |
| Q1 2023 | $14,318 | +79.1% | 256,636 | +17.0% | 0.01% | +66.7% |
| Q4 2022 | $7,993 | -99.9% | 219,338 | -2.5% | 0.00% | 0.0% |
| Q3 2022 | $6,404,000 | -39.7% | 224,871 | -4.2% | 0.00% | -25.0% |
| Q2 2022 | $10,621,000 | -21.8% | 234,701 | +15.1% | 0.00% | 0.0% |
| Q1 2022 | $13,575,000 | -53.5% | 203,917 | +4.0% | 0.00% | -55.6% |
| Q4 2021 | $29,207,000 | -2.7% | 196,072 | -4.9% | 0.01% | 0.0% |
| Q3 2021 | $30,009,000 | -76.6% | 206,130 | -69.4% | 0.01% | -76.3% |
| Q2 2021 | $128,387,000 | -32.4% | 674,419 | -35.8% | 0.04% | -36.7% |
| Q1 2021 | $190,000,000 | +24.2% | 1,049,726 | -2.9% | 0.06% | +15.4% |
| Q4 2020 | $153,034,000 | +22.6% | 1,080,745 | +7.9% | 0.05% | +8.3% |
| Q3 2020 | $124,856,000 | +360.7% | 1,001,406 | +212.8% | 0.05% | +336.4% |
| Q2 2020 | $27,101,000 | – | 320,156 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |